☆ 3.8 Article

Evaluation of Drug Interactions in Hospitalized Patients with Respiratory Disorders in Greece

ADVANCES IN RESPIRATORY MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

Investigating Potential Drug-Drug Interactions from Greek e-Prescription Data

Panagiotis-Nikolaos Lalagkas et al.

Summary: The study aimed to determine the prevalence of potential drug-drug interactions (pDDIs) among outpatients and identify factors associated with their occurrence. The results showed that the prevalence of pDDIs in Greece was higher than in other European countries, with polypharmacy being a potential risk factor.

CURRENT DRUG SAFETY (2022)

添加到收藏夹

Review Respiratory System

Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases

Eusebi Chiner-Vives et al.

Summary: COVID-19, declared as a pandemic by the World Health Organization, has affected millions of people worldwide, especially those with underlying chronic illnesses. The virus can worsen pre-existing respiratory diseases and cause severe symptoms such as respiratory distress and pneumonia.

ARCHIVOS DE BRONCONEUMOLOGIA (2022)

添加到收藏夹

Article Medicine, General & Internal

Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece

Marios Spanakis et al.

Summary: This study evaluated the prevalence and clinical significance of potential drug-drug interactions (DDIs) in COVID-19 patients admitted to a hospital in Greece. The results showed a high occurrence of DDIs in these patients, with clinically significant DDIs being associated with prolonged hospitalization. The study suggests that healthcare teams should address and resolve the additional burden of DDIs in COVID-19 patients.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system

Ziyang Wu et al.

Summary: This study identified the top drugs associated with the risk of torsades de pointes (TdP) using the FDA Adverse Event Reporting System (FAERS) database, and found that some drugs with potential TdP risk were not listed on the QT drug lists of CredibleMeds (R).

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

添加到收藏夹

Review Respiratory System

Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review

Natasha Cordeiro Dos Santos et al.

Summary: This study aimed to describe the prevalence of comorbidities associated with chronic obstructive pulmonary disease (COPD) and their relation with relevant outcomes. The most common comorbidities in COPD patients were hypertension, coronary artery disease, diabetes, osteoarthritis, psychiatric conditions, and asthma. These comorbidities had an impact on COPD exacerbations, quality of life, and mortality risk, particularly malignancies, coronary artery disease, chronic heart failure, and cardiac arrhythmias.

TUBERCULOSIS AND RESPIRATORY DISEASES (2022)

添加到收藏夹

Article Geriatrics & Gerontology

Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients

Dario Cattaneo et al.

Summary: This study assessed the risk of DDIs and PIMs in COVID-19 patients at hospital discharge. It found a significant increase in the prescription of proton pump inhibitors and heparins at discharge, resulting in a higher risk of potentially severe DDIs.

DRUGS & AGING (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece

Marios Spanakis et al.

Summary: The study identified an increased burden of DDIs and DDSIs mostly upon admission for patients in cardiothoracic surgery clinics in Greece. 60% of patients were using dietary supplements and perceived them as safe, but the majority had not informed their treating physician. Healthcare providers should always consider the possibility of DDIs and the use of dietary supplements by patients before promoting their well-being.

PHARMACEUTICS (2021)

添加到收藏夹

Article Respiratory System

Hospital admission trends due to respiratory diseases in England and Wales between 1999 and 2019: an ecologic study

Abdallah Y. Naser et al.

Summary: This study revealed a significant increase in hospital admission rates due to respiratory diseases from 1999 to 2019, with higher rates among male patients. The age group of 75 years and above accounted for a significant proportion of total hospital admissions. Further observational studies are needed to identify risk factors for these admissions and provide relevant interventions.

BMC PULMONARY MEDICINE (2021)

添加到收藏夹

Review Environmental Sciences

Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments

Marios Spanakis et al.

Summary: This article discusses the challenges faced by healthcare systems globally during the COVID-19 pandemic, including drug repositioning and the negative impacts of drug interactions on patient treatment outcomes.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

添加到收藏夹

Review Medicine, General & Internal

The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19

Heloisa Antoniella Braz-de-Melo et al.

Summary: COVID-19 severity is associated with hypercoagulation and exacerbated inflammation, both influenced by ACE2 downregulation and cytokine storm occurrence. Heparin and dexamethasone are discussed as effective drugs for managing severe COVID-19 patients, but the use of dexamethasone should be carefully considered in relation to underlying medical conditions and the severity of the disease.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Article Respiratory System

Clinical characteristics and outcomes of polypharmacy in chronic obstructive pulmonary disease patients: A cross-sectional study from Crete, Greece

Despo Ierodiakonou et al.

Summary: Polypharmacy and multimorbidity are highly prevalent in COPD patients, potentially leading to worse health outcomes and prescription risks. Effective management of these patients may face additional challenges.

CLINICAL RESPIRATORY JOURNAL (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients

Marta Karazniewicz-Lada et al.

Summary: Anti-epileptic drugs (AEDs) are a crucial group of medications used for treating epilepsy, and understanding their pharmacokinetic interactions, especially in COVID-19 patients, is essential for effective management of the condition. The study also highlights the potential drug-drug interactions of AEDs with other medications and the impact of nutrients on their pharmacokinetics.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Drug-drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain

M. D. Cantudo-Cuenca et al.

Summary: The study aimed to evaluate the prevalence and severity of drug-drug interactions in COVID-19 therapies and concomitant medications, finding a high rate of real and potential DDIs among hospitalized patients. Both comorbidities and polypharmacy were independently associated with the development of DDIs, highlighting the importance of monitoring and managing interactions in clinical practice.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Review Medicine, General & Internal

Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic

Shiva Rattan Ambardar et al.

Summary: This paper explores the long-term respiratory complications of severe COVID-19 infection, highlighting potential risks and discussing strategies for prevention.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Medicine, General & Internal

Managing drug-induced QT prolongation in clinical practice

Rani Khatib et al.

Summary: Many drug therapies can prolong the QT interval and increase the risk of Torsades de Pointes. Consideration of patient-related risk factors, the potential risk of QT prolongation with a drug, and co-prescribed medicines that may increase the risk are crucial when prescribing drugs associated with QT prolongation.

POSTGRADUATE MEDICAL JOURNAL (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Polypharmacy: A general review of definitions, descriptions and determinants

Jordan Guillot et al.

THERAPIE (2020)

添加到收藏夹

Article Medicine, General & Internal

Risk factors for potential drug-drug interactions in patients with chronic obstructive pulmonary disease

Dobrivoje Stojadinovic et al.

IRISH JOURNAL OF MEDICAL SCIENCE (2020)

添加到收藏夹

Article Geriatrics & Gerontology

Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease

Clarisse Roux-Marson et al.

BMC GERIATRICS (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Therapeutic Drug Monitoring of Direct Oral Anticoagulants May Increase Their Benefit-Risk Ratio

Marjorie Bernier et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)

添加到收藏夹

Article

Drug interactions for elderly with respiratory disorders and times of COVID-19: a systematic scoping review

Marcela Forgerini et al.

Vitae (2020)

添加到收藏夹

Article Environmental Sciences

Impact of Adverse Drug Reactions in Patients with End Stage Renal Disease in Greece

Marios Spanakis et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Interventions to reduce medication errors in adult medical and surgical settings: a systematic review

Elizabeth Manias et al.

THERAPEUTIC ADVANCES IN DRUG SAFETY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacodynamic Drug-Drug Interactions

Jin Niu et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2017

Jingjing Yu et al.

DRUG METABOLISM AND DISPOSITION (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPD

Jana Graf et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2018)

添加到收藏夹

Article Medicine, General & Internal

Examining patterns of multimorbidity polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study

Peter Hanlon et al.

BMJ OPEN (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

High Prevalence of Drug-Drug Interactions in Primary Health Care is Caused by Prescriptions from other Healthcare Units

Marine L. Andersson et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)

添加到收藏夹

Review Geriatrics & Gerontology

What is polypharmacy? A systematic review of definitions

Nashwa Masnoon et al.

BMC GERIATRICS (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Adverse Drug Reactions Related to Drug Administration in Hospitalized Patients

Luca Gallelli et al.

CURRENT DRUG SAFETY (2017)

添加到收藏夹

Article Rheumatology

Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry

J. H. Salmon et al.

ANNALS OF THE RHEUMATIC DISEASES (2016)

添加到收藏夹

Article Pharmacology & Pharmacy

Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials

Barbara Wisniowska et al.

BMC PHARMACOLOGY & TOXICOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010

Bruce Guthrie et al.

BMC MEDICINE (2015)

添加到收藏夹

Article Urology & Nephrology

Comorbidity as a driver of adverse outcomes in people with chronic kidney disease

Marcello Tonelli et al.

KIDNEY INTERNATIONAL (2015)

添加到收藏夹

Article Medical Laboratory Technology

Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline

Caroline Gjestad et al.

THERAPEUTIC DRUG MONITORING (2015)

添加到收藏夹

Article Medicine, General & Internal

Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease

Tina Roblek et al.

ARCHIVES OF MEDICAL SCIENCE (2014)

添加到收藏夹

Review Public, Environmental & Occupational Health

Drug-Induced Hyperkalemia

Chaker Ben Salem et al.

DRUG SAFETY (2014)

添加到收藏夹

Letter Respiratory System

Polypharmacy in patients hospitalised for acute exacerbation of COPD

Jesus Diez-Manglano et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

添加到收藏夹

Article Psychology, Clinical

Meta-Analysis of Selective Serotonin Reuptake Inhibitor-Associated QTc Prolongation

Scott R. Beach et al.

JOURNAL OF CLINICAL PSYCHIATRY (2014)

添加到收藏夹

Article Public, Environmental & Occupational Health

Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis

Supinya Dechanont et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)

添加到收藏夹

Article Pharmacology & Pharmacy

Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile

Andreas Clemens et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

QT Prolongation and Torsade de Pointes Induced by Fluoroquinolones: Infrequent Side Effects from Commonly Used Medications

Alexandros Briasoulis et al.

CARDIOLOGY (2011)

添加到收藏夹

Article Pharmacology & Pharmacy

Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece

Anna Chatsisvili et al.

PHARMACY WORLD & SCIENCE (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

Mechanisms of Drug Induced QT Interval Prolongation

Marcelo Luis Ponte et al.

CURRENT DRUG SAFETY (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

Frequency and nature of drug-drug interactions in a Dutch university hospital

Jeannette E. F. Zwart-van Rijkom et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

Circos: An information aesthetic for comparative genomics

Martin Krzywinski et al.

GENOME RESEARCH (2009)

添加到收藏夹

Review Endocrinology & Metabolism

Drug-Induced Hypoglycemia: A Systematic Review

M. Hassan Murad et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

添加到收藏夹

Article Rheumatology

Abatacept and serious respiratory infections in patients with previous lung disease

Karla L. Miller et al.

CLINICAL RHEUMATOLOGY (2008)

添加到收藏夹

Article Medicine, General & Internal

Risk factors for potential drug interactions in general practice

Lars Bjerrum et al.

European Journal of General Practice (2008)

添加到收藏夹

Review Pharmacology & Pharmacy

Literature review and pilot studies of the effect of QT correction formulas on reported β2-agonist-induced QTc prolongation

Milos Milic et al.

CLINICAL THERAPEUTICS (2006)

添加到收藏夹

Article Medicine, General & Internal

Adverse drug reactions: definitions, diagnosis, and management

IR Edwards et al.

LANCET (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.